DaVita Inc. stock is up 32.48% since 30 days ago. The next earnings date is Feb 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62.07% of the previous 28 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 10 CALLs. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
01 Dec 16:36 | 15 Dec, 2023 | 105.00 | 891 | ||
01 Dec 17:25 | 15 Dec, 2023 | 100.00 | 1966 | ||
01 Dec 17:41 | 15 Dec, 2023 | 100.00 | 1966 | ||
01 Dec 17:55 | 15 Dec, 2023 | 95.00 | 1702 | ||
01 Dec 20:40 | 19 Apr, 2024 | 80.00 | 196 | ||
04 Dec 14:47 | 15 Dec, 2023 | 95.00 | 1727 | ||
04 Dec 16:16 | 15 Dec, 2023 | 97.50 | 1276 | ||
04 Dec 17:42 | 15 Dec, 2023 | 87.50 | 591 | ||
04 Dec 19:32 | 15 Dec, 2023 | 97.50 | 1276 | ||
05 Dec 20:26 | 19 Apr, 2024 | 115.00 | 366 |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients. The company provides acute inpatient dialysis. services in approximately 850 hospitals and related laboratory services.